Veracyte, Inc.

Veracyte, Inc.

Veracyte, Inc.

Veracyte, a pioneer in molecular cytology, develops molecular diagnostic tests that enable doctors to choose to avoid unnecessary invasive procedures.
Founded
2008
Raised
$116M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$45,000,000
Debt financing - 2016
$28,000,000
Venture capital (Series C) - 2013
Kleiner Perkins Caufield & Byers TPG Biotech GE Ventures +2
Team Size
50+
Employees
Xconomy

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

MedCity News

Veracyte partners with J&J on development of lung cancer test